mometasone furoate
Selected indexed studies
- Mometasone furoate nasal spray for the treatment of asthma. (Expert Opin Investig Drugs, 2016) [PMID:27218300]
- Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma. (Expert Rev Respir Med, 2022) [PMID:34783265]
- [Mometasone furoate]. (Ugeskr Laeger, 1991) [PMID:1926632]
_Worker-drafted node — pending editorial review._
Connections
mometasone furoate is a side effect of
Sources
- Mometasone furoate nasal spray for the treatment of asthma. (2016) pubmed
- Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma. (2022) pubmed
- [Mometasone furoate]. (1991) pubmed
- Mometasone furoate nasal spray: a review of safety and systemic effects. (2007) pubmed
- Mometasone furoate sinus implant - a new targeted approach to treating recurrent nasal polyp disease. (2018) pubmed
- Intranasal corticosteroid and antihistamine combinations in the treatment of allergic rhinitis: the role of the novel formulation olopatadine/mometasone furoate. (2023) pubmed
- Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma. (2021) pubmed
- Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids. (2018) pubmed
- Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children. (2009) pubmed
- Mometasone furoate: a review of its intranasal use in allergic rhinitis. (2008) pubmed